Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 18,481-18,492 of 23,847
Drug study icon
CompletedNCT04414930

Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In San Diego
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
Drug study icon
CompletedNCT01652378

Pharmacologic MRI in Cocaine Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In Dallas
AddictionDrugFrom 21 Years to 64 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Addiction
Drug study icon
WithdrawnNCT05939765

Pharmacologic Treatment in Legal Offenders With Schizophrenia, a Prospective Observational Mirror Image Study.

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

In Zurich
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Switzerland
Sponsor
Psychiatric University Hospital, Zurich
Condition
Schizophrenia
Drug study icon
CompletedNCT00078767

Pharmacologic Treatment of PTSD in Sexually Abused Children

This summary needs review. Please check the official study record and contact the research team for details.

In Pittsburgh
PTSDDrugFrom 10 Years to 17 Years
Countries
United States
Sponsor
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Condition
PTSD
Drug study icon
CompletedNCT04559529

Pharmacological Modulation of Hippocampal Activity in Psychosis 2

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

In Nashville
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Vanderbilt University Medical Center
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.